Free Trial
NASDAQ:NEXI

NexImmune (NEXI) Stock Price, News & Analysis

NexImmune logo
$0.24 +0.03 (+14.29%)
(As of 11/20/2024 ET)

About NexImmune Stock (NASDAQ:NEXI)

Key Stats

Today's Range
$0.21
$0.24
50-Day Range
$0.20
$0.38
52-Week Range
$0.20
$28.69
Volume
5,015 shs
Average Volume
2,127 shs
Market Capitalization
$333,600.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a product candidate targeted against HPV related cancers, which is in Phase I/II clinical trials. It provides NEXI-004 which is in preclinical stage for EBV related diseases; and NEXI005 designs for patient with specific targets for solid tumors. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.

Receive NEXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NexImmune and its competitors with MarketBeat's FREE daily newsletter.

NEXI Stock News Headlines

NexImmune (NASDAQ:NEXI) Stock Price Down 17.8% - What's Next?
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…
NexImmune moves forward with wind-down process
NEXI Stock Alert: NexImmune Delists From Nasdaq
What Is Going on With NexImmune (NEXI) Stock Today?
See More Headlines

NEXI Stock Analysis - Frequently Asked Questions

NexImmune's stock was trading at $2.22 at the beginning of 2024. Since then, NEXI shares have decreased by 89.2% and is now trading at $0.24.
View the best growth stocks for 2024 here
.

NexImmune, Inc. (NASDAQ:NEXI) posted its quarterly earnings data on Friday, November, 12th. The company reported ($16.25) earnings per share (EPS) for the quarter, beating the consensus estimate of ($16.75) by $0.50.

NexImmune shares reverse split on the morning of Thursday, October 19th 2023. The 1-25 reverse split was announced on Wednesday, October 18th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, October 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

NexImmune (NEXI) raised $75 million in an initial public offering (IPO) on Friday, February 12th 2021. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. Barclays, Cantor, Raymond James and Allen & Co. acted as the underwriters for the IPO.

Shares of NEXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that NexImmune investors own include Athenex (ATNX), Achilles Therapeutics (ACHL), TherapeuticsMD (TXMD), Bolt Biotherapeutics (BOLT), KLX Energy Services (KLXE), Lannett (LCI) and Exela Technologies (XELA).

Company Calendar

Last Earnings
11/12/2021
Today
11/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:NEXI
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Net Income
$-32,340,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$3.32 per share

Miscellaneous

Free Float
1,187,000
Market Cap
$334,800.00
Optionable
Not Optionable
Beta
1.66
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

This page (NASDAQ:NEXI) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners